Tafamidis – March 2026

Capsule 61 mg

  • Brand names:
    • Vyndamax®
  • Pharmaceutical Company:
    • PFIZER AUSTRALIA PTY LTD
  • Condition/Indication: Transthyretin amyloid cardiomyopathy (ATTR-CM)
  • Meeting Date: March 2026
Public Summary Documents
Last updated
11 March 2026